Accelerate Diagnostics: 4Q Earnings Snapshot

·1 min read

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Tuesday reported a loss of $18.9 million in its fourth quarter.

On a per-share basis, the Tucson, Arizona-based company said it had a loss of 33 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.

The maker of systems that diagnose drug-resistant infections posted revenue of $3.1 million in the period.

For the year, the company reported that its loss narrowed to $78.2 million, or $1.40 per share. Revenue was reported as $11.2 million.

Accelerate Diagnostics shares have increased 47% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $11.15, a fall of 28% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXDX at https://www.zacks.com/ap/AXDX